Fingerprint
Dive into the research topics of 'Benefits of the combination of thalidomide plus cyclophosphamide in hormone refractory prostate cancer patients'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Benefits of the combination of thalidomide plus cyclophosphamide in hormone refractory prostate cancer patients
Tania Al-Chalabi, William Douglas Figg*
*Corresponding author for this work
Research output: Contribution to journal › Comment/debate